Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have surged notably to become dominant in the United States and South Africa, respectively(1,2). These new subvariants carrying further mutations in their spike proteins raise concerns that they may further evade neutralizing antibodies, thereby fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qian, Guo, Yicheng, Iketani, Sho, Nair, Manoj S., Li, Zhiteng, Mohri, Hiroshi, Wang, Maple, Yu, Jian, Bowen, Anthony D., Chang, Jennifer Y., Shah, Jayesh G., Nguyen, Nadia, Chen, Zhiwei, Meyers, Kathrine, Yin, Michael T., Sobieszczyk, Magdalena E., Sheng, Zizhang, Huang, Yaoxing, Liu, Lihong, Ho, David D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385487/
https://www.ncbi.nlm.nih.gov/pubmed/35790190
http://dx.doi.org/10.1038/s41586-022-05053-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385487/
https://www.ncbi.nlm.nih.gov/pubmed/35790190
http://dx.doi.org/10.1038/s41586-022-05053-w

Ejemplares similares